WGCNA combined with GSVA to explore biomarkers of refractory neocortical epilepsy

Rui Zhang1, Yan Chen1, Jia He1

  • 1Department of Epilepsy and Sleep Disorder, Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, 150086, Harbin, China.

IBRO Neuroscience Reports
|October 17, 2022
PubMed

Insights

Epilepsy surgery relapse is high due to unknown molecular causes. This study identified key genes and pathways in epilepsy zones linked to seizure frequency, offering potential biomarkers for new treatments.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Epilepsy surgery has a high relapse rate, often linked to an incomplete understanding of underlying molecular mechanisms.
  • Current treatments for refractory epilepsy are limited by a lack of knowledge regarding the specific biological pathways involved.

Purpose of the Study:

  • To identify molecular differences between the epileptogenic zone (EZ) and irritative zone (IZ) in refractory neocortical epilepsy.
  • To uncover key genes and biological pathways associated with seizure frequency in epilepsy patients.

Main Methods:

  • Weighted Gene Co-expression Network Analysis (WGCNA) and Gene Set Variation Analysis (GSVA) were applied to RNA sequencing data from 20 surgical samples.
  • Analysis focused on differentiating molecular signatures between EZ and IZ, and correlating gene expression with seizure frequency.

Main Results:

  • Distinct molecular pathways were identified in the EZ (late estrogen response, IL6-JAK-STAT3, G2 checkpoints) and IZ (early estrogen response, TGF-β).
  • Allogeneic rejection and TGF-β signaling correlated with high seizure frequency, while unfolded protein response and MYC-target were linked to low seizure frequency.
  • Specific genes (OSR2, CABP4, CAPSL, CYP4F8, FRK, SH3GLB2, CHAC1, DDX23) were identified as significantly correlated with seizure frequency.

Conclusions:

  • The epileptogenic zone and irritative zone exhibit distinct molecular mechanisms.
  • Identified genes and pathways serve as potential biomarkers for developing novel preventive and pharmacological interventions for epilepsy.

Related Concept Videos